(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SCIPIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SCIPIO

ST13

US500000097560035

Class

1, 9, 10, 42

Filing

97560035

Registration

7075166

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

06/06/2023

Trademark type

Word

Nice classes

1, 9, 10, 42

Filing date

08/23/2022

Registration date

06/06/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/06/2023

Last transaction

06/06/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Montrouge, FR

Examiner

ADORNO SANTOS, LUZ

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

S. B. (pessoa física)

Representatives

PINA CAMPAGNA CARTER, DELUCA AND FARRELL LLP

Technical classification

Nice Classes

Class 1Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals for use in science; biological and chemical preparations for use in science; Chemical and biological reagents used in scientific apparatus for chemical or biological analysis; chemical preparations for laboratory analysisfor use in science; Chemicalbiochemicalbiological and biotechnological preparations for scientific purposesother than for medical or veterinary use; molecules and biomoleculesreagentsenzymesantibody fragmentsantibodiesall intended for researchbiotechnological product development and medical research

Class 9

Downloadable and recorded computer software applications in the medical field for collectingprocessingmonitoringanalyzing cell data; Downloadable and recorded computer software and mobile applications used in connected medical devices for collectingprocessinganalyzing cell data; Downloadable and recorded computer software used for biologicalchemical and medical analysis; Downloadable and recorded computer software used for medical diagnosis; Scientificresearchweighingmeasuringdetectingtestinginspection apparatus and instruments for collectingprocessingmonitoringanalyzing cellsmoleculesRNADNA; Chemistry apparatus and instrumentsresearch laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; Testing apparatustesting sample collection equipmenttest tubes for use in diagnostic testingnot for medical purposes; Diagnostic apparatusfor the detection of gene expressionnot for medical purposes; Observation instrumentsmedical laboratory research instruments for gene expressioncellmoleculeDNARNA analysis; Laboratory robots

Class 10

Medical and surgical devices and instrumentsdevices for collectingprocessingmonitoring and analyzing cellsmoleculesDNARNA; Testing apparatus for testing cellsmoleculesDNARNA for medical purposes; Diagnostic apparatus for testing cancer cellsDNAfor medical purposes; robots for medical userobotic diagnostic apparatus for testing cancer cellsDNA

Class 42

Scientific and technological servicesresearch and design in the field of gene expression; chemical analysis services; Biological research; Bacteriological research; Chemical research; Medical research; Scientific research; Scientific laboratory services; Research and development of new products for others; biochemical research and development; research and development in the pharmaceuticalbiomedical and biotechnological fields; laboratory researchanalysisevaluationdevelopment and conducting clinical trial for others of therapeuticpreventive and diagnostic compositions and treatments; Conducting scientific and medical research for third parties; Consulting services in the fields of pharmaceutical researchchemistrybiotechnology; Custom synthesiscustom design and development of chemical substances for medicalscientifictechnological applications; Chemical and biological development services for medicalscientifictechnological applicationsdevelopment of biochemicalgenetic and transcriptomic assays; Chemical and biological laboratory services; Conducting chemical and biological analyses; Custom design and development of chemical reagents; Designinstallationupdatingmaintenance of computer software used for biologicalchemical and medical analysis; Designinstallationupdatingmaintenance of computer software used for medical diagnosis; Software as a service (SaaS) services featuring software for biologicalchemicalmedical analysismedical diagnosis

Publications

History of USPTO decisions and trademark events.

16 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

06/06/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/21/2023

PUBO

PUBLISHED FOR OPPOSITION

03/21/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/13/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

02/13/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/13/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

02/13/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/13/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/20/2022

GNRT

NON-FINAL ACTION E-MAILED

12/20/2022

CNRT

NON-FINAL ACTION WRITTEN

12/20/2022

DOCK

ASSIGNED TO EXAMINER

12/19/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2022

NWAP

NEW APPLICATION ENTERED

08/26/2022

Continuous trademark protection

Get notified about every new filing that threatens SCIPIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.